Span-America to Nominate Thomas J. Sullivan to Board of Directors
November 18 2014 - 11:40AM
Business Wire
Span-America Medical Systems, Inc. (NASDAQ: SPAN) announced
that Thomas J. Sullivan will be nominated for election to the Board
of Directors at the Company’s next annual meeting, which is
expected to be held in February, 2015. Mr. Sullivan currently
serves as President, CEO and Director of Symmetry Medical Inc.
(NYSE: SMA).
“If he is elected, we look forward to having Tom Sullivan join
Span-America’s Board of Directors,” stated Thomas D. Henrion,
Chairman of the Board of Span-America Medical Systems, Inc. “He has
significant leadership experience across a broad range of
healthcare disciplines, including sales and marketing of capital
goods in the medical market, encompassing our largest business
segment. In addition, his knowledge of the Canadian healthcare
markets will be important as we expand our market opportunities for
our Canadian subsidiary, M.C. Healthcare Products.”
Mr. Sullivan (age 50) currently serves as President, CEO and
Director of Symmetry Medical Inc. (NYSE:SMA). Symmetry Medical is a
leading global source of innovative medical device solutions,
including surgical instruments, sterilization cases and trays, and
orthopedic implants. Prior to joining Symmetry Medical in 2011, Mr.
Sullivan was President, Supply Chain & Business Processes,
Johnson & Johnson Health Care Systems Inc.; President of Depuy
Orthopeadics, Inc., a Johnson & Johnson Company; and President
of Johnson & Johnson Medical Products Canada. Mr. Sullivan
began his career at Johnson & Johnson in 1990 in the areas of
strategic planning and operations. Mr. Sullivan graduated as a
Palmer Scholar from The Wharton School in 1991 where he earned an
MBA in Strategic Management and Management Information Systems. He
also holds a Bachelor of Science degree (magna cum laude) in
Computer Science and Applied Mathematics from the University of
Pittsburgh.
Mr. Sullivan has been nominated to fill the unexpired term of
Richard Coggins. Mr. Coggins has submitted his resignation from the
Board of Directors to be effective as of the beginning of the 2015
Annual Meeting of Shareholders. Mr. Coggins will continue to serve
as Chief Financial Officer, Vice President of Finance and Secretary
of the Company, and after the 2015 annual meeting, he will continue
to attend Board meetings in his role as Secretary. Span-America’s
Board of Directors is limited to nine members. If elected, Mr.
Sullivan would serve as a member of the Board of Directors for the
remainder of Mr. Coggins’ current term, which expires at the
Company’s 2017 Annual Meeting of Shareholders.
About Span-America Medical Systems, Inc.
Span-America manufactures and markets a comprehensive selection
of pressure management products for the medical market, including
Geo-Matt®, PressureGuard®, Geo-Mattress®, Custom Care®, Span+Aids®,
Isch-Dish®, Risk ManagerTM and Selan® products. We also supply
custom foam and packaging products to the consumer
and industrial markets. Through our
wholly-owned subsidiary Span Medical Products Canada Inc., we
manufacture and market the M.C. Healthcare Products
brands of EncoreTM, Maxxum, Advantage and Rexx bed frames as
well as related case goods, tables and seating products for the
long-term care market. Span-America’s stock is traded on The
NASDAQ Global Market under the symbol “SPAN.” For more
information, visit www.spanamerica.com and
www.mchealthcare.com.
Forward-Looking Statements
We have made forward-looking statements in this release. We wish
to caution the reader that these statements are only predictions.
These forward-looking statements may be generally identified by the
use of forward-looking words and phrases such as “will,” “intends,”
“may,” “believes,” “anticipates,” “would,” “should” and “expects,”
and are based on the company’s current expectations or beliefs
concerning future events that involve risks and uncertainties.
Actual events or results may differ materially as a result of risks
and uncertainties facing the company, including: (a) the inability
to achieve anticipated sales growth in the medical and custom
products segments, (b) the possibility of disruptions in our
consumer products business related to the transfer of our exclusive
distribution agreement from Louisville Bedding Company to Hollander
Home Fashions in May 2013 as a result of the sale of Louisville
Bedding’s utility bedding retail business to Hollander, (c) the
possibility of a loss of a key customer or distributor for our
products, (d) risks related to international operations and foreign
exchange associated with our Canadian subsidiary, (e) the
possibility of having material uncollectible receivables from one
or more key customers or distributors, (f) the potential for
volatile pricing conditions in the market for polyurethane foam,
(g) raw material cost increases, (h) the possibility that some or
all of our medical products could be determined to be subject to
the 2.3% medical device excise tax imposed by the Affordable Care
Act, (i) the potential for lost sales due to competition from
low-cost foreign imports, (j) changes in relationships with large
customers or key suppliers, (k) the impact of competitive
products and pricing, (l) government reimbursement changes in
the medical market, (m) FDA and Health Canada regulation of medical
device manufacturing and (n) other risks referenced from time
to time in our Securities and Exchange Commission filings. We
disclaim any obligation to update publicly any forward-looking
statement, whether as a result of new information, future events or
otherwise. We are not responsible for changes made to this document
by wire services or Internet services.
Span-America Medical Systems, Inc.Jim Ferguson, 864-288-8877,
ext. 6912President and Chief Executive Officer
Span America (NASDAQ:SPAN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Span America (NASDAQ:SPAN)
Historical Stock Chart
From Jul 2023 to Jul 2024